Lobbying client
CUREMARK LLC
Biotechnology and development company
Filings
7
Filed by
1
Reported in-house
—
Reported by firms
$120,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2010 to 2012
Filings
4 filings for 2011, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Report 4th Quarter 2011
|
VAN SCOYOC ASSOCIATES | $20,000 reported |
|
3rd Quarter - Report 3rd Quarter 2011
|
VAN SCOYOC ASSOCIATES | $30,000 reported |
|
2nd Quarter - Report 2nd Quarter 2011
|
VAN SCOYOC ASSOCIATES | $30,000 reported |
|
1st Quarter - Report 1st Quarter 2011
|
VAN SCOYOC ASSOCIATES | $30,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| VAN SCOYOC ASSOCIATES | 6 | $120,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Budget/Appropriations | BUD | 6 |
| Medical/Disease Research/Clinical Labs | MED | 6 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.